Navigation Links
PAREXEL Reaches Milestone in Management of Oncology Trials Over Last Five Years Involving 175,000 Patients Worldwide
Date:5/27/2009

BOSTON, May 27 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, today announced it has reached a milestone in managing oncology-based clinical trials over the last five years, which have involved over 175,000 patients in hundreds of programs across 80 countries. PAREXEL will be marking this milestone during the American Society of Clinical Oncology (ASCO) Annual Meeting, to be held May 29 - June 2, 2009 in Orlando, Florida. PAREXEL's hematology and oncology experts will be available during the ASCO meeting at Booth #1980 to discuss their capabilities to support the successful development of novel cancer treatments.

"Significant advances in targeted therapies for cancer have generated more competition for patient populations. To meet industry demand for conducting cancer trials across a broad range of indications, PAREXEL continues to leverage our global footprint and ability to manage complex programs on a worldwide scale to help biopharmaceutical companies access diverse patient populations, navigate regulatory issues, and identify effective investigators," said Mark A. Goldberg, M.D., Chief Operating Officer, PAREXEL International.

"With approximately 10 million people diagnosed with cancer each year worldwide, PAREXEL works with biopharmaceutical companies toward the goals of improving the development success rate for oncology drugs and getting treatments to patients sooner," said Denis R. Miller, M.D., Senior Medical Director, Clinical Research Services, PAREXEL. "Our global team of hematology and oncology experts helps clients advance important innovations through our understanding of unmet medical needs, the standards of available cancer care worldwide, and how new anticancer agents will be positioned in the treatment of patients, from th
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
2. PAREXEL Expands Global Clinical Pharmacology Capabilities
3. PAREXEL Data Reveal A Record High Number of Clinical Trials Initiated
4. PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru
5. Enrollment Reaches 110 Patients in Investigator Initiated, Randomized Trial of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM)
6. Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter
7. CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema
8. Cancer Pioneer Reaches Key Agreement on Colon Cancer Drug OncoVAX(R)
9. CureHIV Reaches Out to Bill and Melinda Gates to Fund LiSAVIOR
10. Genmab Reaches Milestone in Ofatumumab Collaboration
11. Neurobiological Technologies Reaches Patient Enrollment Target For Interim Analysis of Viprinex(TM) Phase 3 Stroke Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)...  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) announced today ... and update at the Piper Jaffray 26 th Annual ... Eastern Time (5:30 a.m. Pacific Time), at The New York ... A live audio webcast of the presentation will be ... www.arenapharm.com . A replay of the presentation will be ...
(Date:11/24/2014)... , Nov. 24, 2014 /PRNewswire/ - Milestone Pharmaceuticals, ... trial conducted in Melbourne, Australia ... for the potential treatment of paroxysmal supraventricular tachycardia ... of MSP-2017 was well tolerated at single doses ... excellent safety profile, desirable PK properties including rapid ...
(Date:11/24/2014)... , Nov. 24, 2014  Marta Rendon, MD, founder ... Boca Raton , FL and international key opinion leader ... from the United States to attend ... Istanbul, Turkey . Here, at this gathering of ... as world renowned facial plastic surgery experts from ...
Breaking Medicine Technology:Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 3Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 2Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 3Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 2Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 3
... DIEGO, Nov. 18 Rules-Based Medicine, Inc. (RBM) today announced ... with Covance Inc. (NYSE: CVD ) that will ... biomarker technologies and services for use in drug development. Under ... exclusive third-party provider of multiplexed protein biomarker testing services, and ...
... , , TEMECULA, Calif., Nov. 17 ... announced third quarter 2009 results. , "We are continuing ... increases in our gross margins," stated Steven H. Kane, ... third quarter revenues from sales of safety sponges were ...
Cached Medicine Technology:Rules-Based Medicine Forms Biomarker Alliance With Covance Inc. 2Rules-Based Medicine Forms Biomarker Alliance With Covance Inc. 3Patient Safety Technologies Reports Third Quarter Results 2Patient Safety Technologies Reports Third Quarter Results 3Patient Safety Technologies Reports Third Quarter Results 4Patient Safety Technologies Reports Third Quarter Results 5Patient Safety Technologies Reports Third Quarter Results 6
(Date:11/26/2014)... OR (PRWEB) November 26, 2014 The ... fresh water shortages, is moving forward with a plan ... drinking water.* Radio host Sharon Kleyne supports the San ... “Total Water Management” (TWM). According to Kleyne, by recycling ... constantly import new water could be greatly reduced. (Spagat, ...
(Date:11/26/2014)... Loffler Companies has been selected as ... an online information and news publication for resellers of ... consecutive year Loffler has earned this prestigious award and ... Dealer Awards honor the best and the brightest in ... honorees were chosen for their innovative marketing and sales ...
(Date:11/26/2014)... WOODLAND HILLS, CA (PRWEB) November 26, 2014 ... implants costing thousands of dollars, the prosthodontists at the Anacapa ... that paying for dental procedures can be daunting for some. ... to pay for the procedures they offer. , “No dentist ... functioning and beautiful set of teeth,” said Dr. Mamaly Reshad, ...
(Date:11/26/2014)... Senior Planning Services, providing “expert guidance for ... providing the adult demographic education and access to ... the rough seas of applying for Medicaid. Part of ... topic of Medicaid eligibility and proper planning, while also ... for this coverage. , Senior Planning Services has ...
(Date:11/26/2014)... ISI Telemanagement Solutions, Inc., a ... award the 2014 Lync Pioneer Award ... as a great honor to ISI, who continues ... Specifically, ISI offers an integrated collaboration reporting and ... including voice, video, Lync IM, and conferencing. ...
Breaking Medicine News(10 mins):Health News:Global fresh water advocate supports San Diego wastewater recycling plan 2Health News:Global fresh water advocate supports San Diego wastewater recycling plan 3Health News:Loffler Companies Recognized as an Elite Dealer for Sixth Consecutive Year 2Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 2Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 3Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 4Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 5Health News:Senior Planning Services Teams Up with SeniorNet To Educate Seniors On Medicaid Planning 2Health News:ISI Telemanagement Solutions, Inc. has been Awarded the 2014 Microsoft Lync Pioneer Award 2
... French and Spanish . , Researchers from ... belonging to the Laboratorio de Ciencias de la Visin y Aplicaciones, ... the tool required to implement it, which has been named "halometer". ... and a computer where the mouse is used as a response ...
... the old journalistic adage goes. Not necessarily, say researchers from ... of the Jewish General Hospital. In a first-of-its kind study ... versus 20 years ago, positivity and hope seem to be ... potential impact on patient perspectives," said Dr. Melissa Henry, the ...
... Epidemiology Unit, Southampton, UK, and Dr. Michal Hiligsmann ... with the ESCEO Young Investigator Awards, supported by a ... European Congress on Osteoporosis & Osteoarthritis (ECCEO11-IOF) now taking ... 2,500, recognize young investigators for their excellence in bone ...
... March 23, 2011 Although acupuncture is commonly used ... remain. Investigators from the Universities of Exeter & Plymouth ... (Daejeon, South Korea) critically evaluated systematic reviews of acupuncture ... this question. Reporting in the April 2011 issue of ...
... with Sichuan University in Chengdu, China, investigated eye movements in ... mechanisms that control them and how they compare between different ... movement, that is rare in British people, is much more ... differences in brain function between different populations. ...
... By Amanda Gardner HealthDay Reporter , ... developed a new way of predicting when breast cancer ... "epigenetic signatures" seem to distinguish more aggressive cancers from ... Epigenetic alterations do not involve changes to the ...
Cached Medicine News:Health News:Researchers develop a halometer that tests alterations in night vision 2Health News:Researchers develop a halometer that tests alterations in night vision 3Health News:Good news! Hope makes headlines 2Health News:Acupuncture for pain no better than placebo and not without harm 2Health News:Eye movement differs in British and Chinese populations 2Health News:Genes' 'On/Off' Switches Yield Clues to Breast Cancer 2Health News:Genes' 'On/Off' Switches Yield Clues to Breast Cancer 3
... is effective against gram positive and gram ... interfering with bacterial protein synthesis by binding ... suggested working concentration of 50 mg/L is ... thereby making a gentler alternative to penicillin ...
... new approach to practice management, built to address ... healthcare market. OPIE was created by practicing O&P ... in this field, so it thinks the way ... than anything else available. If you believe there ...
... new hand-held Slit Lamp HSL150 with an ... For Human and Veterinary medicine for the ... an ergonomic, compact,design, the new HEINE HSL ... slit lamp is not available,or practical to ...
... used for endophotocoagulation indications, ... uncompromised laser treatment of ... handpieces are compatible with ... (532 nm), OcuLight infrared ...
Medicine Products: